# PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE)

> **NCT03514719** · PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** 89Zr-avelumab PET
- **DRUG:** Avelumab

## Key facts

- **NCT ID:** NCT03514719
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2021-09-15
- **Final completion:** 2021-12-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03514719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03514719, "PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03514719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*